Psivant Therapeutics
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.psivant.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Psivant Therapeutics
PsiThera is focused on developing oral therapies for immunology targets, particularly those within the tumor necrosis factor (TNF) superfamily, where no oral treatments currently exist. Utilizing their QUAISAR platform, they model biologically relevant protein motion to identify druggable states and design small molecules for diseases typically treated with injected biologics. Their innovative approach combines computational intelligence and integrated structural biophysics to enhance drug discovery and decision-making processes. PsiThera aims to provide patients with effective oral medications that offer biologic-like efficacy without the need for injections.Explore more
Psivant Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Psivant Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Psivant Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Psivant Therapeutics
Click to see if Psivant Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Psivant Therapeutics launches new products
Check if Psivant Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Psivant Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Psivant Therapeutics has new funding data
Check out if Psivant Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Psivant Therapeutics
Find more new buyers
Compare Similar Companies to Psivant Therapeutics
Compare insights from companies similar to Psivant Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Psivant Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Psivant Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Psivant Therapeutics.
Psivant Therapeutics Tech Stack
A closer look at the technologies used by Psivant Therapeutics
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Cloud, Product Marketing, Events, Infrastructure, Engineering, Clinical Systems, Data Management, Data Science, Machine Learning, Sales, Enterprise Software, Software, Bioengineering, Pharmaceuticals, Field /Outside Sales, Artificial Intelligence, Clinical Operations, Field Marketing, Healthcare Technology, Operations
Person-Based
Person-Based
Psivant Therapeutics News & Media
OpenFold AI Research Consortium Welcomes Six New Members: Astex, Biogen, Congruence, Polaris Quantum, Psivant, and SandboxAQ
DAVIS, Calif.--(BUSINESS WIRE)--The non-profit consortium is developing publicly accessible advanced AI-based drug discovery software tools.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Psivant Therapeutics
Sign Up For FreeTo access detailed company insights
PsiThera is focused on developing oral therapies for immunology targets, particularly those within the tumor necrosis factor (TNF) superfamily, where no oral treatments currently exist. Utilizing their QUAISAR platform, they model biologically relevant protein motion to identify druggable states and design small molecules for diseases typically tre... Read More
